Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Amyloidosis Incidence in High-Risk Cardiac Device Patients

Study ID: NCT06186167
Start Date: 2024-01-29
End Date: 2024-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Chest Wall Fat Tissue Collection

Sponsor

Midwest Heart & Vascular Specialists

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Study ID: NCT06005740
Start Date: 2023-12-04
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

TORL-4-500

Sponsor

TORL Biotherapeutics, LLC

Source: clinicaltrials.gov

Share:
Add to list

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

Study ID: NCT04599140
Start Date: 2020-10-14
End Date: 2026-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

CXCR1/2 Inhibitor SX-682

Nivolumab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer

Study ID: NCT05130840
Start Date: 2022-07-13
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

MRI

Lumbar puncture

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer

Study ID: NCT05427240
Start Date: 2022-09-28
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Pre-Test Intervention

Standard of Care

Post-Test Intervention

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Study ID: NCT04151940
Start Date: 2019-09-26
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Positron Emission Tomography

Computed Tomography

Chemotherapy

Immunotherapy

Radiation Therapy

Biospecimen Collection

Magnetic Resonance Imaging

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Study ID: NCT04777994
Start Date: 2021-03-09
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

248

Intervention / Treatment

ABBV-CLS-484

Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)

Programmed Cell Death-1 (PD-1) Inhibitor

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors

Study ID: NCT06480240
Start Date: 2024-06-12
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

117

Intervention / Treatment

OBI-992

Sponsor

OBI Pharma, Inc

Source: clinicaltrials.gov

Share:
Add to list

Study of SGR-3515 In Participants With Advanced Solid Tumors.

Study ID: NCT06463340
Start Date: 2024-06-18
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

52

Intervention / Treatment

SGR-3515

Sponsor

Schrödinger, Inc.

Source: clinicaltrials.gov

Share:
Add to list

CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Study ID: NCT06035744
Start Date: 2023-12-12
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

86

Intervention / Treatment

Cln-617

Pembrolizumab

Sponsor

Cullinan Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list